Leading global law firm Herbert Smith Freehills Kramer has advised China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and other underwriters on Nexchip Semiconductor Corporation (02249.HK, 688249.SS)'s listing on the Main Board of the Hong Kong Stock Exchange.
"Nexchip Semiconductor's listing reflects the continued depth of Hong Kong's capital markets for high-quality technology and advanced manufacturing issuers," said Hong Kong partner Jason Sung. "It also highlights Hong Kong's important role in connecting leading A-share listed companies with international investors."
Nexchip Semiconductor is a leading pure-play foundry specialising in 12-inch wafer manufacturing, operating at a critical juncture of the global semiconductor value chain. Its foundry services cover technology nodes ranging from 150nm to 40nm, with the 28nm Logic IC platform successfully developed. The company achieved the fastest growth in production capacity and revenue among the global top-ten wafer foundries from 2020 to 2025, ranking as the ninth-largest wafer foundry worldwide and the third-largest in Mainland China by revenue in 2025.
The company's process capabilities are centred on key application-specific IC categories, including display driver ICs, CMOS image sensors and power management ICs, supporting applications across consumer electronics, automotive electronics, industrial control, artificial intelligence, the Internet of Things and memory.
"We congratulate Nexchip Semiconductor on its successful Hong Kong listing and are pleased to have advised the sponsor and underwriters on the transaction," said Hong Kong partner Jin Kong*. "The transaction drew on our experience advising leading Chinese technology and advanced manufacturing companies, as well as our strong Hong Kong execution capability."
Herbert Smith Freehills Kramer has a strong track record advising on cross‑border China capital markets transactions, including Hong Kong listings of A‑share listed companies such as S.F. Holding Co., Ltd. (06936.HK, 002352.SZ), Jiangsu Hengrui Pharmaceuticals Co., Ltd. (01276.HK, 600276.SS), Shanghai Longcheer Technology Co., Ltd. (09611.HK, 603341.SS), Eastroc Beverage (Group) Co., Ltd. (09980.HK, 605499.SS), Mabwell (Shanghai) Bioscience Co., Ltd. (02493.HK, 688062.SS) and Luxshare Precision Industry Co., Ltd. (02475.HK, 002475.SZ).
Partners Jason Sung and Jin Kong led a cross-office team advising the client, assisted by Sean Ji, Crystal Chan, Camille Chai, Cassey Wu, Ariel Liu, Emily Wan, Allen Wang, Mello Wang and Tasmine Khaw. Francis Wang and Eric Zhou also provided assistance.
Legal manager Marine Jin led Herbert Smith Freehills Kewei Joint Operation's Digital Legal Delivery business to provide high-efficiency solutions for verification and other document-intensive processes during the listing, assisted by Grace Ji and Huidan Luo.
*Due to regulatory requirements in Hong Kong, Jin Kong's official title is Senior Registered Foreign Lawyer.